AU2003216830A1 - Purification methods for oligonucleotides and their analogs - Google Patents
Purification methods for oligonucleotides and their analogsInfo
- Publication number
- AU2003216830A1 AU2003216830A1 AU2003216830A AU2003216830A AU2003216830A1 AU 2003216830 A1 AU2003216830 A1 AU 2003216830A1 AU 2003216830 A AU2003216830 A AU 2003216830A AU 2003216830 A AU2003216830 A AU 2003216830A AU 2003216830 A1 AU2003216830 A1 AU 2003216830A1
- Authority
- AU
- Australia
- Prior art keywords
- oligonucleotides
- analogs
- purification methods
- purification
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36706002P | 2002-03-21 | 2002-03-21 | |
US60/367,060 | 2002-03-21 | ||
PCT/GB2003/001161 WO2003080834A2 (en) | 2002-03-21 | 2003-03-19 | Purification methods for oligonucleotides and their analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003216830A1 true AU2003216830A1 (en) | 2003-10-08 |
Family
ID=28454833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003216830A Abandoned AU2003216830A1 (en) | 2002-03-21 | 2003-03-19 | Purification methods for oligonucleotides and their analogs |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1490488A2 (en) |
JP (1) | JP2005520547A (en) |
KR (1) | KR20040108672A (en) |
CN (1) | CN1643145A (en) |
AU (1) | AU2003216830A1 (en) |
CA (1) | CA2479901A1 (en) |
WO (1) | WO2003080834A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006132588A1 (en) * | 2005-06-10 | 2006-12-14 | Quiatech Ab | Method for the purification of synthetic oligonucleotides containing one or several labels |
DE102005059315A1 (en) * | 2005-12-09 | 2007-06-14 | Qiagen Gmbh | Process for the enrichment of short-chain nucleic acids |
AU2012205204B2 (en) * | 2005-12-09 | 2015-03-12 | Qiagen Gmbh | Method for enriching short-chain nucleic acids |
GB2443505B (en) | 2006-09-26 | 2008-12-31 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
GB2445441B (en) | 2006-09-26 | 2010-06-30 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
GB2445442A (en) | 2006-09-26 | 2008-07-09 | Ge Healthcare Bio Sciences | Nucleic acid purification using anion exchange |
DE102008063003A1 (en) | 2008-12-23 | 2010-06-24 | Qiagen Gmbh | Nucleic acid purification method |
JP5914338B2 (en) * | 2009-09-24 | 2016-05-11 | キアジェン ゲイサーズバーグ インコーポレイテッド | Compositions, methods and kits for nucleic acid isolation and analysis using anion exchange materials |
CN102753705A (en) * | 2009-12-14 | 2012-10-24 | B·吴 | Method and materials for separating nucleic acid materials |
EP2760999A1 (en) * | 2011-09-26 | 2014-08-06 | Qiagen GmbH | Methods for separating nucleic acids by size |
CN103833797A (en) * | 2012-11-26 | 2014-06-04 | 福建金山生物制药股份有限公司 | Industrial method for purifying phosphorothioate oligodeoxynucleotide |
US10745686B2 (en) | 2013-02-08 | 2020-08-18 | Qiagen Gmbh | Method for separating DNA by size |
CN106632558B (en) * | 2016-08-25 | 2019-09-13 | 淮阴师范学院 | A kind of purification method and application of oligonucleotide |
CA3110524A1 (en) | 2018-09-11 | 2020-03-19 | Amgen Inc. | Purification methods for guanine-rich oligonucleotides |
EP3997100A1 (en) * | 2019-07-09 | 2022-05-18 | F. Hoffmann-La Roche AG | Process for the deprotection of oligonucleotides |
EP4070102A1 (en) * | 2019-12-05 | 2022-10-12 | Waters Technologies Corporation | Polyphosphonic acids for improving recovery and minimizing system loss |
CN111394427B (en) * | 2020-04-22 | 2023-04-11 | 宁波市博坤生物科技有限公司 | Method for extracting trace DNA in soil-containing test material |
CN116209757A (en) * | 2020-07-14 | 2023-06-02 | 沃特世科技公司 | Compositions, kits and methods for separating oligonucleotides from matrix components |
WO2024053578A1 (en) | 2022-09-07 | 2024-03-14 | 株式会社日本触媒 | Nucleic acid production method, method for removing impurities, and nucleic acid having less impurities |
JPWO2024089953A1 (en) * | 2022-10-27 | 2024-05-02 | ||
EP4556572A1 (en) * | 2023-11-20 | 2025-05-21 | Sartorius BIA Separations d.o.o. | Method for purifying one or more target nucleic acid(s) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0755400A1 (en) * | 1994-04-08 | 1997-01-29 | HYBRIDON, Inc. | Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography |
US6310199B1 (en) * | 1999-05-14 | 2001-10-30 | Promega Corporation | pH dependent ion exchange matrix and method of use in the isolation of nucleic acids |
GB9927904D0 (en) * | 1999-11-25 | 2000-01-26 | Amersham Pharm Biotech Ab | A method fro obtaining a nucleic acid variant |
DE10010342A1 (en) * | 2000-03-06 | 2001-09-20 | Merck Patent Gmbh | Method for reducing the endotoxin content of nucleic acid (I) is derived from natural, genetic engineering or biotechnological sources is used to produce high-purity plasmid DNA from natural sources |
-
2003
- 2003-03-19 WO PCT/GB2003/001161 patent/WO2003080834A2/en not_active Application Discontinuation
- 2003-03-19 KR KR10-2004-7014747A patent/KR20040108672A/en not_active Withdrawn
- 2003-03-19 CA CA002479901A patent/CA2479901A1/en not_active Abandoned
- 2003-03-19 JP JP2003578560A patent/JP2005520547A/en active Pending
- 2003-03-19 EP EP03712366A patent/EP1490488A2/en not_active Withdrawn
- 2003-03-19 AU AU2003216830A patent/AU2003216830A1/en not_active Abandoned
- 2003-03-19 CN CNA03806393XA patent/CN1643145A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1643145A (en) | 2005-07-20 |
KR20040108672A (en) | 2004-12-24 |
WO2003080834A2 (en) | 2003-10-02 |
CA2479901A1 (en) | 2003-10-02 |
JP2005520547A (en) | 2005-07-14 |
EP1490488A2 (en) | 2004-12-29 |
WO2003080834A3 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL262513A (en) | Protein purification | |
IL190247A0 (en) | Methods for purifying sucralose | |
IL163662A0 (en) | Methods for purifying sucralose | |
EG24449A (en) | Purification process | |
AU2003216830A1 (en) | Purification methods for oligonucleotides and their analogs | |
SI2261230T1 (en) | Protein purification method | |
GB0405884D0 (en) | Modified nucleotides | |
AU2003217003A1 (en) | Water purification apparatus | |
AU2003272454A1 (en) | Protein purification | |
AU2003226529A1 (en) | Purification process | |
AU2003288553A1 (en) | Process for purifying oligonucleotide synthons | |
AU2002310296A1 (en) | Rna purification methods | |
AU2002358767A1 (en) | Purification process of aromatics | |
AU2003210629A1 (en) | Methods for the integrated synthesis and purification of oligonucleotides | |
AUPS334902A0 (en) | Purification method | |
AU2003206331A1 (en) | Methods for separating oligonucleotides | |
AU2003264383A1 (en) | Purifying vessel | |
TWI350829B (en) | Purification process | |
AU2003247740A1 (en) | Process for purifying and isolating rac-bicalutamide | |
GB0327179D0 (en) | Purification method | |
AU2003207119A1 (en) | Method for purifying simvastatin | |
AU2003241762A1 (en) | Dna shuflling | |
AU2002312012A1 (en) | Gas purification system | |
AU2003235841A1 (en) | Purification system | |
AU2003228944A1 (en) | Protein complex purification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |